FierceBiotech 25. Nov. 2025 <a href="https://www.fiercebiotech.com/biotech/versants-dayra-dawns-50m-biogen-pact-oral-macrocyclic-peptide-mission" hreflang="en">Versant's Dayra dawns with $50M Biogen pact, oral macrocyclic peptide mission</a> #Dayra Therapeutics #Versant Ventures
Endpoints News 24. Nov. 2025 Biogen pens I&I deal with new Versant macrocycle developer Dayra Therapeutics #Versant Ventures’ #Dayra Therapeutics